ATE477820T1 - Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten - Google Patents

Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten

Info

Publication number: ATE477820T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; treatment; oral administration; obesity patients; obesity
Prior art date: 2007-09-12

Application number

AT07425563T

Other languages

English (en)

Inventor

Guido Vandoni

Heny Cassia Zaniboni

Original Assignee

Mader S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-12

Filing date

2007-09-12

Publication date

2010-09-15

2007-09-12 Application filed by Mader S R L filed Critical Mader S R L

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE477820T1 publication Critical patent/ATE477820T1/de

Links

208000008589 Obesity Diseases 0.000 title abstract 2
235000020824 obesity Nutrition 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Obesity (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Child & Adolescent Psychology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT07425563T 2007-09-12 2007-09-12 Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten ATE477820T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07425563A EP2036575B1 (de)	2007-09-12	2007-09-12	Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten

Publications (1)

Publication Number	Publication Date
ATE477820T1 true ATE477820T1 (de)	2010-09-15

Family

ID=38983405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07425563T ATE477820T1 (de)	2007-09-12	2007-09-12	Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten

Country Status (10)

Country	Link
US (1)	US20100221326A1 (de)
EP (1)	EP2036575B1 (de)
JP (1)	JP2010539137A (de)
AT (1)	ATE477820T1 (de)
AU (1)	AU2008300030A1 (de)
CA (1)	CA2698882A1 (de)
DE (1)	DE602007008567D1 (de)
ES (1)	ES2350798T3 (de)
PL (1)	PL2036575T3 (de)
WO (1)	WO2009034171A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100958197B1 (ko)	2008-02-20	2010-05-14	(주)국전약품	올리스타트를 포함하는 약학적 조성물 및 이의 제조 방법
BRPI0901602B8 (pt) *	2009-04-03	2021-05-25	Ems S/A	formulação farmacêuticas
CN108785272B (zh) *	2018-09-04	2019-04-09	中山万汉制药有限公司	一种奥利司他软胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9807655A (pt) *	1997-02-05	2000-02-15	Hoffmann La Roche	Uso de inibidores de lipase gastrintestinal.
AR025587A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas
WO2003009840A1 (en) *	2001-07-24	2003-02-06	Lonza Ag	Composition comprising at least one lipase inhibitor and carnitine
IL162323A0 (en) *	2001-12-04	2005-11-20	Biogal Pharmaceutical Co	Preparation of orlistat and orlistat crystalline forms
EP1501498B1 (de) *	2002-04-26	2009-12-30	F. Hoffmann-La Roche Ag	Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
EP1591114A1 (de) *	2004-03-12	2005-11-02	Fournier Laboratories Ireland Limited	Verwendung von Metformin und Orlistat zur Behandlung oder Vorbeugung von Obesität

2007
- 2007-09-12 ES ES07425563T patent/ES2350798T3/es active Active
- 2007-09-12 EP EP07425563A patent/EP2036575B1/de not_active Not-in-force
- 2007-09-12 PL PL07425563T patent/PL2036575T3/pl unknown
- 2007-09-12 AT AT07425563T patent/ATE477820T1/de not_active IP Right Cessation
- 2007-09-12 DE DE602007008567T patent/DE602007008567D1/de active Active
2008
- 2008-09-12 JP JP2010524504A patent/JP2010539137A/ja active Pending
- 2008-09-12 WO PCT/EP2008/062165 patent/WO2009034171A1/en not_active Ceased
- 2008-09-12 US US12/678,066 patent/US20100221326A1/en not_active Abandoned
- 2008-09-12 CA CA2698882A patent/CA2698882A1/en not_active Abandoned
- 2008-09-12 AU AU2008300030A patent/AU2008300030A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE602007008567D1 (de)	2010-09-30
JP2010539137A (ja)	2010-12-16
EP2036575B1 (de)	2010-08-18
US20100221326A1 (en)	2010-09-02
PL2036575T3 (pl)	2011-02-28
WO2009034171A1 (en)	2009-03-19
EP2036575A1 (de)	2009-03-18
AU2008300030A1 (en)	2009-03-19
ES2350798T3 (es)	2011-01-27
CA2698882A1 (en)	2009-03-19

Similar Documents

Publication	Publication Date	Title
EP1851237A4 (de)	2009-01-07	Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
EA201190217A1 (ru)	2012-04-30	Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201000914A1 (ru)	2010-12-30	Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA200901032A1 (ru)	2010-02-26	Соединения и композиции в качестве модуляторов активности gpr119
UA107783C2 (en)	2015-02-25	Isoindoline compounds for use in treating cancer
EP2415763A4 (de)	2012-08-15	Pharmazeutische zusammensetzungen zur behandlung oder prävention von glaukom
EA201290184A1 (ru)	2012-12-28	Бензодиазепиновый ингибитор бромодомена
DK1970059T3 (da)	2009-12-21	Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
EA201100138A1 (ru)	2011-08-30	4-феноксиметилпиперидины в качестве модуляторов активности gpr119
CY1108794T1 (el)	2014-04-09	Σπειροκυκλικα παραγωγα κυκλοεξανιου
EA201071045A1 (ru)	2011-02-28	Соединения оксадиазоантрацена для лечения диабета
TN2011000209A1 (en)	2012-12-17	Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
LTC1781298I2 (lt)	2018-09-25	Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
CY1117326T1 (el)	2017-04-26	Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson
EP2135858A4 (de)	2012-02-08	Zusammensetzung zur behandlung von infektionserkrankungen
ATE525070T1 (de)	2011-10-15	Silbininkomponente zur behandlung von hepatitis
CY1115725T1 (el)	2017-01-25	Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
MY147677A (en)	2012-12-31	Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
DE602006006712D1 (de)	2009-06-18	Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
CY1116234T1 (el)	2017-02-08	Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
MA32841B1 (fr)	2011-11-01	Composés de cycloundeca depsipeptides et leur utilisation comme médicament
EA201200428A1 (ru)	2013-02-28	Композиция и способ для лечения ожирения
CY1114760T1 (el)	2016-12-14	Θεραπευτικη αγωγη αθηροσκληρωσης
ATE552257T1 (de)	2012-04-15	Positive allosterische chinolizidinon-m1- rezeptormodulatoren
MX2009013197A (es)	2010-04-27	Derivados terapeuticos de pirazolonaftiridina.

Legal Events

Date	Code	Title	Description
2011-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties